A team of scientists at King’s College London has developed an Artificial Intelligence model which analyses immune responses in the lymph nodes to predict the likelihood of developing secondary breast cancer for patients with triple negative breast cancer. Lymph nodes are small bean-shaped structures that are part of the body’s immune system. They filter substances…
Details
Last year Nolan rode a zipwire to raise money for Secondary1st. This year he’s planning to undertake a more down to earth challenge. In September he will cycle more than 1000 km, riding all the way from Land’s End to John O’Groats, travelling from one end of the country to the other. He is training…
Details
Not content with skydiving, running a marathon and organizing a fitness challenge to raise money for Secondary1st our superhero Tim ran in the Brighton Marathon and then after a gap of only three weeks he’s going to run in the London Marathon. He really is a superhero.
In June 2022 we reported that favourable results from a trial of a new cancer drug, Enhertu (trastuzumab deruxtecan), had been presented at this year’s meeting of the American Society of Clinical Oncology and had been published in the “New England Journal of Medicine”. Enhertu is a specifically engineered HER-2-directed antibody drug conjugate which has…
Details
Dr Coffelt and his team at the Beatson Institute for Cancer Research in Glasgow in another project funded by Secondary1st’s fundraisers and donors are working to understand why existing immunotherapies are less effective in treating breast cancer than other cancer types. They recently published a report on a significant discovery that breast cancer immunotherapy could…
Details
At the University of Bradford in one of the projects funded by the wonderful donors and fundraisers of Secondary1st Professor Pors and his PhD student Enrica are continuing their work to improve duocarmycins, a very effective but highly toxic chemotherapy, so that they can be used to treat breast cancer. In the second year of…
Details
Staff and students from Francis Holland School Regent’s Park put on fancy dress and took part in a sponsored walk around Regent’s Park to raise money for Secondary1st. The weather was ideal to enjoy an autumn afternoon in the open air and the event raised just over £22,000 thanks to the generosity of everyone who…
Details
In recently published draft guidance NICE has approved the routine use of another drug combination for some people with secondary breast cancer. Palbociclib, also known as Ibrance, is a targeted drug made by Pfizer and is now recommended in combination with fulvestrant for the treatment of hormone receptor positive HER2 negative secondary breast cancer when…
Details
Ruth and Stu are preparing to fly to Nepal where they will take part in a 22-day expedition to the summit of Imja Tse, the Nepalese name of Island Peak. Imja Tse is 6200 metres high and is in the Sagarmatha National Park on the Himalayas of eastern Nepal. Island Peak received its English name…
Details
Paul will be running the London Marathon on 2nd October to raise money for Secondary1st in memory of his sister-in-law Poppy. He has been training hard through the summer heat and completed an 18-mile run during the Bank Holiday weekend. He is planning 3 more long runs before Marathon Day.
Catherine did it and more! She walked the length of Hadrian’s Wall and then walked on for another seventeen miles to raise money for Secondary1st. She crossed the country from Wallsend near Newcastle to Bowness-on-Solway near Carlisle keeping any prevailing winds at her back to help her along her journey.
Catherine has spent weeks and weeks preparing for August 2nd when she will set off to walk the 100km length of Hadrian’s Wall east to west across the north of England from Wallsend to Bowness-on-Solway. She hopes to mark the 1900th anniversary of the Wall by completing her walk in eight days.